Article Versions Notes

Lee JS, Oh Y, Park JH, Kyung SY, Kim HS, Yoon S. Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity. International Journal of Molecular Sciences. 2022; 23(22):13809. https://doi.org/10.3390/ijms232213809

Lee, Ji Sun, Yunmoon Oh, Jae Hyeon Park, So Young Kyung, Hyung Sik Kim, and Sungpil Yoon. 2022. "Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity" International Journal of Molecular Sciences 23, no. 22: 13809. https://doi.org/10.3390/ijms232213809

Lee, J. S., Oh, Y., Park, J. H., Kyung, S. Y., Kim, H. S., & Yoon, S. (2022). Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity. International Journal of Molecular Sciences, 23(22), 13809. https://doi.org/10.3390/ijms232213809